Beam Therapeutics Inc.BEAM
Price (close)
$24.27
Market cap
$2.5B
P/E
—
Revenue (TTM)
$156.0M
Net income
-$85.4M
Dividend yield
—
1-year total return
5.1%
Net margin
-54.7%
Revenue growth
158.9%
Debt / equity
0.09x
What Beam Therapeutics Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $24,000 | $51.8M | $60.9M | $377.7M | $63.5M | $139.7M |
| Net income | -$194.6M | -$370.6M | -$289.1M | -$132.5M | -$376.7M | -$80.0M |
| Free cash flow | -$112.1M | -$113.1M | -$26.4M | -$182.9M | -$356.2M | -$360.0M |
More on BEAM.
- Beam Therapeutics Inc. summary
- Beam Therapeutics Inc. financial statements
- Beam Therapeutics Inc. key metrics
- Beam Therapeutics Inc. health scores and style box
- Beam Therapeutics Inc. earnings
- Beam Therapeutics Inc. dividends
- Beam Therapeutics Inc. valuation
- Beam Therapeutics Inc. ownership and insiders
- Beam Therapeutics Inc. peers
Figures from Beam Therapeutics Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.